The global cold, cough, and sore throat remedy market size was exhibited at USD 42.89 billion in 2024 and is projected to hit around USD 59.98 billion by 2034, growing at a CAGR of 3.41% during the forecast period 2024 to 2034.
When a person is experiencing symptoms of cold, cough, and sore throat that make them feel uncomfortable or make it hard to fall asleep, then remedies are recommended. Respiratory infections show symptoms of cold, cough and sore throat which is caused by bacteria, viruses, fungi, and mycoplasma. According to the U.S. Centers for Disease Control and Prevention, the amount of acute respiratory illness causing people to seek healthcare is moderate nationally. The rising incidence of respiratory infections is increasing the adoption of the cold, cough, and sore throat remedy market.
Moreover, it is essential to spread awareness about over-the-counter medicine which is easily accessible and does not require any prescription. The availability of OTC medicines has gained popularity for cold, cough, and sore throat remedies. The future of the cold, cough, and sore throat remedy market is expected to witness growth with the incorporation of oral syrups. These are highly competitive in the cold and cough industry. It offers a convenient approach for consumers to experience fast and effective relief. Geographically, India holds the largest market share due to the trusted blend of ayurvedic formulations.
Cold, Cough, and Sore Throat Remedy Market Segmentation:
By Drug
- Antihistamines
- Expectorants
- Bronchodilators
- Decongestants
- Antibiotics
- Others
By Doses
- Oral Syrups
- Tablets/Pills
- Nasal Drops
- Lozenges
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Supermarkets/Hypermarkets
- E-Commerce/Online Pharmacies
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Cold, Cough, and Sore Throat Remedy Market Companies:
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com